in a multicenter , double-blind trial , 284 patients with gastroesophageal reflux disease were evaluated before , during , and after six weeks of treatment with either placebo or ranitidine ( 150 mg twice daily ) .
C0017168
gastroesophageal reflux
C0034665
ranitidine